Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Allison

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapyE D Kwon, B A Foster, A A Hurwitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1978
Murine Ia and human DR antigens: homology of amino-terminal sequencesJ P Allison, L E Walker, W A Russell, et al.
Immunological Reviews|October 1, 1996
The role of CTLA-4 in the regulation and initiation of T-cell responsesC A Chambers, M F Krummel, B Boitel, et al.
Experimental Cell Research|June 1, 1985
Identification of dipeptidyl peptidase IV as a protein shared by the plasma membrane of hepatocytes and liver biomatrixE F Walborg, S Tsuchida, D S Weeden, et al.
Journal of Clinical Immunology|November 1, 1987
The gamma T-cell antigen receptorL L Lanier, A T Serafini, J J Ruitenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 1997
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancerE D Kwon, A A Hurwitz, B A Foster, et al.
Gene Therapy|February 28, 2014
Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancerJ C Morris, C A Ramlogan-Steel, P Yu, et al.
Cancer Research|May 16, 2000
Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockadeA A Hurwitz, B A Foster, E D Kwon, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activationT J Sullivan, J J Letterio, A van Elsas, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Limited diversity of T-cell receptor gamma-chain expression of murine Thy-1+ dendritic epidermal cells revealed by V gamma 3-specific monoclonal antibodyW L Havran, S Grell, G Duwe, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapyE D Kwon, B A Foster, A A Hurwitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1978
Murine Ia and human DR antigens: homology of amino-terminal sequencesJ P Allison, L E Walker, W A Russell, et al.
Immunological Reviews|October 1, 1996
The role of CTLA-4 in the regulation and initiation of T-cell responsesC A Chambers, M F Krummel, B Boitel, et al.
Experimental Cell Research|June 1, 1985
Identification of dipeptidyl peptidase IV as a protein shared by the plasma membrane of hepatocytes and liver biomatrixE F Walborg, S Tsuchida, D S Weeden, et al.
Journal of Clinical Immunology|November 1, 1987
The gamma T-cell antigen receptorL L Lanier, A T Serafini, J J Ruitenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 1997
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancerE D Kwon, A A Hurwitz, B A Foster, et al.
Gene Therapy|February 28, 2014
Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancerJ C Morris, C A Ramlogan-Steel, P Yu, et al.
Cancer Research|May 16, 2000
Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockadeA A Hurwitz, B A Foster, E D Kwon, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activationT J Sullivan, J J Letterio, A van Elsas, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Limited diversity of T-cell receptor gamma-chain expression of murine Thy-1+ dendritic epidermal cells revealed by V gamma 3-specific monoclonal antibodyW L Havran, S Grell, G Duwe, et al.
Pageof 15